<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04403711</url>
  </required_header>
  <id_info>
    <org_study_id>TAP-dexmedetomidine</org_study_id>
    <nct_id>NCT04403711</nct_id>
  </id_info>
  <brief_title>Dexmedetomidine in TAP Block for Inguinal Hernia Repair</brief_title>
  <acronym>TAP-dex</acronym>
  <official_title>The Effect of Adding Dexmedetomidine to the Local Anesthetic Solution for Ultrasonography-guided TAP Block in Inguinal Hernia Repair</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Aretaieion University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Aretaieion University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This prospective double-blind randomized study will aim at evaluating the short- and
      long-term postoperative analgesic efficacy of the ultrasound-guided transversus abdominis
      plane (TAP) block with a combination of local anesthetic and dexmedetomidine in inguinal
      hernia repair under general anesthesia
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Inguinal hernia repair is one of the most commonly performed surgical procedures worldwide,
      especially in the day-case setting. It can be accompanied by moderate to severe postoperative
      pain, which can delay return to normal daily activities or lead to the development of chronic
      pain. Chronic pain after hernia repair has a reported prevalence ranging between 0% and 43%
      with both nociceptive and neuropathic features. The transversus abdominis plane (TAP) block
      is an effective regional anesthetic technique to reduce postoperative pain intensity, time to
      first rescue anesthetic administration and opioid demand after upper and lower abdominal
      surgery. Dexmedetomidine is a selective α2-adrenergic agonist with analgesic properties that
      has been shown to prolong local anesthetic action when used as an adjunct to local anesthetic
      solutions in neuraxial anesthesia. The aim of this prospective, double-blind placebo
      controlled randomized study will be to evaluate the analgesic efficacy of ultrasound-guided
      TAP block where local anesthetic is supplemented by dexmedetomidine in patients undergoing
      unilateral elective inguinal hernia repair with the Lichtenstein technique under general
      anesthesia.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 1, 2018</start_date>
  <completion_date type="Anticipated">December 31, 2023</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>pain score 3 hours postoperatively</measure>
    <time_frame>3 hours after surgery</time_frame>
    <description>pain score by the use of Numeric Rating Scale (NRS) 3 hours postoperatively, ranging from 0 to 10, where 0 means &quot;no pain&quot; and 10 means &quot;worst pain imaginable&quot;</description>
  </primary_outcome>
  <primary_outcome>
    <measure>pain score 6 hours postoperatively</measure>
    <time_frame>6 hours after surgery</time_frame>
    <description>pain score by the use of Numeric Rating Scale (NRS) 6 hours postoperatively, ranging from 0 to 10, where 0 means &quot;no pain&quot; and 10 means &quot;worst pain imaginable&quot;</description>
  </primary_outcome>
  <primary_outcome>
    <measure>pain score 24 hours postoperatively</measure>
    <time_frame>24 hours after surgery</time_frame>
    <description>pain score by the use of Numeric Rating Scale (NRS) 24 hours postoperatively, ranging from 0 to 10, where 0 means &quot;no pain&quot; and 10 means &quot;worst pain imaginable&quot;</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>incidence of chronic pain</measure>
    <time_frame>6 months after surgery</time_frame>
    <description>occurrence of chronic pain at the site of the operation, with the use of the NRS, at rest and during movement</description>
  </secondary_outcome>
  <other_outcome>
    <measure>morphine consumption</measure>
    <time_frame>24 hours postoperatively</time_frame>
    <description>morphine consumption through patient-controlled analgesia device for 24 hours postoperatively</description>
  </other_outcome>
  <other_outcome>
    <measure>satisfaction from postoperative analgesia</measure>
    <time_frame>24 hours postoperatively</time_frame>
    <description>satisfaction from postoperative analgesia on a four-point Likert scale with 1 marked as minimal satisfaction and 4 as maximal satisfaction</description>
  </other_outcome>
  <other_outcome>
    <measure>transversus abdominis plane-related complications</measure>
    <time_frame>48 hours postoperatively</time_frame>
    <description>transversus abdominis plane-related complications at the site of the local anesthetic injection</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Inguinal Hernia</condition>
  <condition>Analgesia</condition>
  <condition>Pain, Acute</condition>
  <condition>Pain, Chronic</condition>
  <condition>Pain, Neuropathic</condition>
  <arm_group>
    <arm_group_label>local anesthetic and dexmedetomidine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>ultrasound-guided transversus abdominis plane block with 25 mL ropivacaine 0.5% and 2 mL dexmedetomidine</description>
  </arm_group>
  <arm_group>
    <arm_group_label>local anesthetic and placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>ultrasound-guided transversus abdominis plane block with 25 mL ropivacaine 0.5% and 2 mL normal saline</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>local anesthetic and dexmedetomidine</intervention_name>
    <description>in patients allocated to the dexmedetomidine group, ultrasound-guided transversus abdominis plane block will be performed with the combination of local anesthetic and dexmedetomidine</description>
    <arm_group_label>local anesthetic and dexmedetomidine</arm_group_label>
    <other_name>medication used in regional anesthetic technique</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>local anesthetic and placebo</intervention_name>
    <description>in patients allocated to the dexmedetomidine group, ultrasound-guided transversus abdominis plane block will be performed with the combination of local anesthetic and normal saline</description>
    <arm_group_label>local anesthetic and placebo</arm_group_label>
    <other_name>medication used in regional anesthetic technique</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  American Society of Anesthesiologists (ASA) patients I-III undergoing inguinal hernia
             repair with a mesh

          -  open hernia repair

          -  elective surgery

        Exclusion Criteria:

          -  inability to consent to the study due to language barriers or cognitive dysfunction -

          -  bilateral inguinal hernia repair,

          -  body mass index over 40 kg m-2,

          -  skin infection at the puncture site

          -  contraindication to paracetamol or non-steroidal anti-inflammatory drug (NSAIDs)
             administration

          -  known previous hepatic or renal impairment as assessed by the patients' history and
             routine biochemical markers

          -  coagulation abnormalities

          -  history of gastroesophageal reflux and preoperative use of opioids or NSAIDs for
             chronic pain conditions

          -  reoperation of recurrent inguinal hernia after previous mesh repair
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kassiani Theodoraki, PhD, DESA</last_name>
    <role>Principal Investigator</role>
    <affiliation>Aretaieion University Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Aretaieion University Hospital</name>
      <address>
        <city>Athens</city>
        <state>Αττική</state>
        <zip>11528</zip>
        <country>Greece</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kassiani Theodoraki, PhD, DESA</last_name>
      <phone>+306974634162</phone>
      <email>ktheodoraki@hotmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Ioannis Koutalas, MD</last_name>
    </contact_backup>
  </location>
  <location_countries>
    <country>Greece</country>
  </location_countries>
  <reference>
    <citation>Bay-Nielsen M, Perkins FM, Kehlet H; Danish Hernia Database. Pain and functional impairment 1 year after inguinal herniorrhaphy: a nationwide questionnaire study. Ann Surg. 2001 Jan;233(1):1-7.</citation>
    <PMID>11141218</PMID>
  </reference>
  <reference>
    <citation>Alfieri S, Amid PK, Campanelli G, Izard G, Kehlet H, Wijsmuller AR, Di Miceli D, Doglietto GB. International guidelines for prevention and management of post-operative chronic pain following inguinal hernia surgery. Hernia. 2011 Jun;15(3):239-49. doi: 10.1007/s10029-011-0798-9. Epub 2011 Mar 2.</citation>
    <PMID>21365287</PMID>
  </reference>
  <reference>
    <citation>Petersen PL, Mathiesen O, Torup H, Dahl JB. The transversus abdominis plane block: a valuable option for postoperative analgesia? A topical review. Acta Anaesthesiol Scand. 2010 May;54(5):529-35. doi: 10.1111/j.1399-6576.2010.02215.x. Epub 2010 Feb 17. Review.</citation>
    <PMID>20175754</PMID>
  </reference>
  <reference>
    <citation>McDonnell JG, O'Donnell B, Curley G, Heffernan A, Power C, Laffey JG. The analgesic efficacy of transversus abdominis plane block after abdominal surgery: a prospective randomized controlled trial. Anesth Analg. 2007 Jan;104(1):193-7. Erratum in: Anesth Analg. 2007 May;104(5):1108.</citation>
    <PMID>17179269</PMID>
  </reference>
  <reference>
    <citation>Mikkelsen T, Werner MU, Lassen B, Kehlet H. Pain and sensory dysfunction 6 to 12 months after inguinal herniotomy. Anesth Analg. 2004 Jul;99(1):146-51.</citation>
    <PMID>15281521</PMID>
  </reference>
  <reference>
    <citation>Goudarzi TH, Kamali A, Yazdi B, Broujerdi GN. Addition of dexmedetomidine, tramadol and neostigmine to lidocaine 1.5% increasing the duration of postoperative analgesia in the lower abdominal pain surgery among children: A double-blinded randomized clinical study. Med Gas Res. 2019 Jul-Sep;9(3):110-114. doi: 10.4103/2045-9912.266984.</citation>
    <PMID>31552872</PMID>
  </reference>
  <reference>
    <citation>Theodoraki K, Papacharalampous P, Tsaroucha A, Vezakis A, Argyra E. The effect of transversus abdominis plane block on acute and chronic pain after inguinal hernia repair. A randomized controlled trial. Int J Surg. 2019 Mar;63:63-70. doi: 10.1016/j.ijsu.2019.02.007. Epub 2019 Feb 12.</citation>
    <PMID>30769214</PMID>
  </reference>
  <reference>
    <citation>Chen Q, Liu X, Zhong X, Yang B. Addition of dexmedetomidine or fentanyl to ropivacaine for transversus abdominis plane block: evaluation of effect on postoperative pain and quality of recovery in gynecological surgery. J Pain Res. 2018 Nov 16;11:2897-2903. doi: 10.2147/JPR.S178516. eCollection 2018.</citation>
    <PMID>30532583</PMID>
  </reference>
  <reference>
    <citation>Ramya Parameswari A, Udayakumar P. Comparison of Efficacy of Bupivacaine with Dexmedetomidine Versus Bupivacaine Alone for Transversus Abdominis Plane Block for Post-operative Analgesia in Patients Undergoing Elective Caesarean Section. J Obstet Gynaecol India. 2018 Apr;68(2):98-103. doi: 10.1007/s13224-017-0990-7. Epub 2017 Apr 26.</citation>
    <PMID>29662278</PMID>
  </reference>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>May 21, 2020</study_first_submitted>
  <study_first_submitted_qc>May 21, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">May 27, 2020</study_first_posted>
  <last_update_submitted>May 26, 2020</last_update_submitted>
  <last_update_submitted_qc>May 26, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 28, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Aretaieion University Hospital</investigator_affiliation>
    <investigator_full_name>Dr Kassiani Theodoraki</investigator_full_name>
    <investigator_title>Professor of Anesthesiology</investigator_title>
  </responsible_party>
  <keyword>transversus abdominis plane block</keyword>
  <keyword>dexmedetomidine</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neuralgia</mesh_term>
    <mesh_term>Hernia</mesh_term>
    <mesh_term>Hernia, Inguinal</mesh_term>
    <mesh_term>Acute Pain</mesh_term>
    <mesh_term>Chronic Pain</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dexmedetomidine</mesh_term>
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Anesthetics, Local</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

